Skip to main content

Table 2 Factors associated with a positive depression screening test

From: Prevalence of depressive symptoms in pregnant and postnatal HIV-positive women in Ukraine: a cross-sectional survey

 

Positive depression screening test

Fisher’s exact test

Antenatal survey

 Living as only adult in household?

  No

25 % (42/167)

p=0.02

  Yes

58 % (7/12)

 

 Severity of ART side effects

  Not bothered by side effects or only slightly

23 % (30/129)

p=0.05

  Somewhat or terribly bothered by side effects

40 % (17/43)

 

 Level of confidence that antenatal ART is effective for PMTCT

  Completely/fairly sure that it is effective

25 % (43/169)

p=0.06

  Not at all sure that it is effective

56 % (5/9)

 

 Self-efficacy score for integration of ART into daily life

  ≥5 (higher self-efficacy)

23 % (25/110)

p=0.05

  <5 (lower self-efficacy)

43 % (12/28)

 

Postnatal survey

 Marital status

  Married

19 % (19/99)

p<0.01

  Co-habiting

21 % (18/84)

 

  Single

44 % (20/45)

 

 Can neonatal prophylaxis help prevent MTCT?

  Yes

18 % (28/154)

p<0.01

  Not sure/No

40 % (25/63)

 

 Ever worried that neonatal prophylaxis could harm baby

  Yes/a little

30 % (44/146)

p<0.01

  No

14 % (10/73)

 

 Self-rated ability to ask for support with taking medicationa

  Confident I could do

15 % (4/26)

p=0.05

  Fairly confident could do

27 % (10/37)

 

  Could not do

48 % (11/23)

 
  1. ART – antiretroviral therapy; MTCT – mother-to-child transmission
  2. aAvailable for 86 of the 101 women on ART at time of postnatal survey completion